Comment on

• Association of angiogenesis related markers with bladder cancer outcomes and other molecular markers.

  Shariat SF, Youssef RF, Gupta A, Chade DC, Karakiewicz PI, Isbarn H, Jeldres C, Sagalowsky AI, Ashfaq R, Lotan Y. Shariat SF, et al. J Urol. 2010 May;183(5):1744-50. doi: 10.1016/j.juro.2010.01.018. Epub 2010 Mar 17. J Urol. 2010. PMID: 20299037
• Marker lesion experiments in bladder cancer--what have we learned?

  Gofrit ON, Zorn KC, Shikanov S, Steinberg GD. Gofrit ON, et al. J Urol. 2010 May;183(5):1678-84. doi: 10.1016/j.juro.2009.12.104. Epub 2010 Mar 17. J Urol. 2010. PMID: 20299042 Review.
• Characteristics and outcomes of patients with clinical carcinoma in situ only treated with radical cystectomy: an international study of 243 patients.

  Tilki D, Reich O, Svatek RS, Karakiewicz PI, Kassouf W, Novara G, Ficarra V, Chade DC, Fritsche HM, Gerwens N, Izawa JI, Lerner SP, Schoenberg M, Stief CG, Skinner E, Lotan Y, Sagalowsky AI, Shariat SF. Tilki D, et al. J Urol. 2010 May;183(5):1757-63. doi: 10.1016/j.juro.2010.01.025. Epub 2010 Mar 17. J Urol. 2010. PMID: 20299059